Introduction
The neuronal ceroid lipofuscinoses (NCLs) are collectively the most common group of inherited pediatric neurodegenerative diseases. Their clinical symptoms include visual impairment, seizures, progressive psychomotor retardation and premature death (Santavuori, 1988) . The NCLs are pathologically defined by a dramatic loss of CNS neurons, but with very few obvious effects outside the brain. All forms of NCL exhibit the characteristic accumulation of lysosomal autofluorescent lipopigments that display subtype specific ultrastructure (Mole et al., 2005) . The NCLs are classified into ten different subtypes (CLN1-CLN10) on the basis of age of onset, clinicopathological features and genetic linkage, with eight genes identified to date (Siintola et al., 2006 (Siintola et al., , 2007 .
The Finnish variant form of late infantile neuronal ceroid lipofuscinosis (vLINCLFin, CLN5) is caused by mutations in the CLN5 gene, originally reported as encoding both soluble and membrane-bound forms of a lysosomal protein (Isosomppi et al., 2002; Vesa et al., 2002) . vLINCL Fin typically appears between 4 and 7 years of age, with the first symptoms usually being motor clumsiness followed by progressive visual failure and blindness, motor and mental deterioration, myoclonia and seizures culminating in an early death between 14 and 36 years (Santavuori et al., 1993; Santavuori et al., 1982) . Although the function of the CLN5 protein has remained elusive, the consensus view is that its predominant form is a soluble lysosomal protein (Sleat et al., 2005) . Several animal models exist for different forms of NCLs and they provide excellent tools for thorough characterization of temporal and spatial pathological cascades (Cooper, 2003; Cooper et al., 2006) . Mouse models of NCL share several common pathological similarities, including selective loss of GABAergic interneuron subpopulations, cortical and thalamic atrophy and pronounced early gliosis (reviewed in Mitchison et al., 2004; Cooper et al., 2006) . More detailed pathological analyses of mouse models of congenital, infantile and juvenile forms of NCL, have all highlighted the thalamocortical pathways in pathogenesis with an early loss of thalamic relay neurons before the onset of neuron loss within the corresponding cortical region (Pontikis et al., 2005; Weimer et al., 2006; Kielar et al., 2007; Partanen et al., 2008) .
Consistent with the milder NCL-phenotype of human vLINCL Fin patients, Cln5
−/− mice exhibit rather mild clinical symptoms (Kopra et al., 2004) . These mice show widespread CNS accumulation of autofluorescent material, progressive visual failure and effects upon GABAergic interneuron survival (Kopra et al., 2004) . Gene expression profiling of Cln5 −/− mice revealed changes in the CNS expression levels for genes related to phosphorylation, cell adhesion, inflammation and myelin integrity (Kopra et al., 2004; von Schantz et al., 2008 
